Cohance Lifesciences Limited (NSE:COHANCE)
India flag India · Delayed Price · Currency is INR
1,064.90
-5.75 (-0.54%)
Jul 22, 2025, 3:30 PM IST

Cohance Lifesciences Company Description

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India.

The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services.

It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals.

The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025.

The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.

Cohance Lifesciences Limited
CountryIndia
Founded1989
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,193
CEOSudhir Singh

Contact Details

Address:
202, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1
Hyderabad, 500081
India
Phone91 40 4475 8595
Websitecohance.com

Stock Details

Ticker SymbolCOHANCE
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE03QK01018
SIC Code2834

Key Executives

NamePosition
Dr. Sudhir Kumar Singh Ph.D.Chief Executive Officer
Vivek Sharma CPAExecutive Chairman
Himanshu AgarwalChief Financial Officer
Cyndrella CarvalhoHead of Investor Relations
Dr. K. Nagendra Babu Ph.D.Chief Quality and Compliance Officer
Gaurav Narain BahadurChief Human Resources Officer
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju Ph.D.MD and Director
Dr. Declan Ryan Ph.D.Chief Commercial Officer
Sunder VenkatramanVice President of Corporate Affairs